Neil O'Connell

New open access paper in @TheJournal_Pain We make a Call to Action to the Pain Research community to make changes to enhance and ensure the trustworthiness of pain research sciencedirect.com/science/articl… . THREAD 1/16

WEBINAR ALERT! Our next @IASPpain Global Year Webinar is on 27th May 8 am EDT. Identification and Clinical Management of Neuropathic Pain: From Evidence to Best Practice. Great speakers and registration is free! perc.iasp-pain.org/products/ident… @EFIC_org @BritishPainSoc @NeuPsig

Register for the 20 May “Advancing Research on the Social Dimensions of Pain: Emerging Evidence and Future Directions” webinar from the Social Aspects of Pain SIG. This webinar will showcase cutting-edge research examining how social factors shape the experience, assessment, and management of pain. bit.ly/3OWVgOf

Be carefull Don’t trust and don’t suscribe to the premium service @opodo This is just a scam

@opodo why do you continue to take money from my account when I have asked to cancel it and have already spoken to the bank about it? You are thieving scam artists. I want the number or the email address to speak to somebody please. #opodo #travel

@opodo the automatic renewal is a scam and even when you cancel they still take the money then offer you credit to spend on flights that Skyscanner does a lot cheaper avoid using this prime subscription

Neil O’Connell, PhD, MSc, BSc (Hons), will address the critical issue of scientific rigor and reproducibility in pain research in his #2026WorldCongressonPain Plenary Lecture. Register to attend: bit.ly/4e0fErL Early Bird Registration Rate Ends 15 May

@seetickets Hi. I’ve not yet received either in the post or E-tickets for Miles Hunt at the Haymarket Basingstoke this Thurs 9/4/25. Please advise

Due to demand @NiallOfficial has announced an additional London date at @TheO2 on Saturday 3rd October! 🤩 Tickets on sale Thursday 2nd April at 10am. 🎟: bit.ly/4140Cd6

Global Year Webinar: Towards Precision Medicine in Neuropathic Pain 1: Using Randomised Trial Evidence to Uncover Individual Treatment Effects ~ 19 March ~ bit.ly/4cmt68P

Episode 6 of Pain Exchange is out now! Listen to this episode to hear Andrew Rice, @LampertLabRWTH, and @NeilOConnell talk about this year’s Global Year campaign raising awareness about neuropathic pain. Listen anywhere you listen to podcasts! bit.ly/3JznbkG

19 March Global Year Webinar: Towards Precision Medicine in Neuropathic Pain 1: Using Randomised Trial Evidence to Uncover Individual Treatment Effects Register: bit.ly/4cmt68P

Register for the first 2026 Global Year webinar “Launching the IASP 2026 Global Year of Neuropathic Pain: What is Neuropathic Pain and Why Does it Matter?” on 29 Jan: bit.ly/3LkYSIa

There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated Cochrane review finds. Read more here: cochrane.org/about-us/news/…

New: A critical appraisal tool for systematic reviews of prognostic factor studies 🔎 Prognostic factor research has increased across fields, with a subsequent increase in the number of systematic reviews of prognostic factors studies bmj.com/content/391/bm…?

Did you ask Santa for a critical appraisal tool for systematic reviews of prognostic factor studies? The new AMSTAR-PF tool is now published in @bmj_latest : lnkd.in/eFPz8SVP Excellent work from Michael Henry @UniversitySA driving this project. @cochranecollab

Massive congratulations to @mcferraro_ who had his PhD conferred this week. Michael was a superb PhD student, he finished his PhD with 12 first author publications (35 in total), and >$200K in funding. I'm looking forward to seeing how his research career develops.

Out today in @AnnalsofIM doi.org/10.7326/ANNALS… Our systematic review of 11 RCTs found bisphosphonates may reduce short-term pain but increase risk for AEs. Results limited by substantial, unexplained heterogeneity, introduced by inclusion of terminated trial data.

Nice summary of advances in pain research in 2025 just out in Lancet Neurology: thelancet.com/journals/laneu… Great to see ENTRUST-PE get a nod! entrust-pe.org